212 related articles for article (PubMed ID: 32848211)
21. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
22. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
Kang SH; Kang KW; Kim KH; Kwon B; Kim SK; Lee HY; Kong SY; Lee ES; Jang SG; Yoo BC
BMC Cancer; 2008 Oct; 8():286. PubMed ID: 18834540
[TBL] [Abstract][Full Text] [Related]
23. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
24. Midazolam suppresses thrombin-induced heat shock protein 27 phosphorylation through inhibition of p38 mitogen-activated protein kinase in cardiac myocytes.
Tanabe K; Akamatsu S; Suga H; Takai S; Kato K; Dohi S; Kozawa O
J Cell Biochem; 2005 Sep; 96(1):56-64. PubMed ID: 16052527
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro.
Singh RK; Diwan M; Dastidar SG; Najmi AK
Hum Exp Toxicol; 2018 May; 37(5):521-531. PubMed ID: 28629242
[TBL] [Abstract][Full Text] [Related]
26. Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex.
Wu R; Kausar H; Johnson P; Montoya-Durango DE; Merchant M; Rane MJ
J Biol Chem; 2007 Jul; 282(30):21598-608. PubMed ID: 17510053
[TBL] [Abstract][Full Text] [Related]
27. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
[TBL] [Abstract][Full Text] [Related]
28. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway.
Paine E; Palmantier R; Akiyama SK; Olden K; Roberts JD
J Biol Chem; 2000 Apr; 275(15):11284-90. PubMed ID: 10753939
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.
Gurgis FM; Ziaziaris W; Munoz L
Mol Pharmacol; 2014 Feb; 85(2):345-56. PubMed ID: 24296859
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus.
Suomalainen M; Nakano MY; Boucke K; Keller S; Greber UF
EMBO J; 2001 Mar; 20(6):1310-9. PubMed ID: 11250897
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.
Pechackova S; Burdova K; Benada J; Kleiblova P; Jenikova G; Macurek L
Oncotarget; 2016 Mar; 7(12):14458-75. PubMed ID: 26883108
[TBL] [Abstract][Full Text] [Related]
32. The p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migration.
Gamell C; Susperregui AG; Bernard O; Rosa JL; Ventura F
PLoS One; 2011 Jan; 6(1):e16477. PubMed ID: 21297993
[TBL] [Abstract][Full Text] [Related]
33. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.
Liu Y; Xu J; Choi HH; Han C; Fang Y; Li Y; Van der Jeught K; Xu H; Zhang L; Frieden M; Wang L; Eyvani H; Sun Y; Zhao G; Zhang Y; Liu S; Wan J; Huang C; Ji G; Lu X; He X; Zhang X
Nat Commun; 2018 Nov; 9(1):4718. PubMed ID: 30413718
[TBL] [Abstract][Full Text] [Related]
34. LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivo.
Tate CM; Blosser W; Wyss L; Evans G; Xue Q; Pan Y; Stancato L
J Biol Chem; 2013 Mar; 288(9):6743-53. PubMed ID: 23335506
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract][Full Text] [Related]
36. Kinase activity, heat shock protein 27 phosphorylation, and lung epithelial cell glutathione.
Jackson RM; Garcia-Rojas R
Exp Lung Res; 2008 Jun; 34(5):245-62. PubMed ID: 18465403
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38
Shrestha A; Bruckmueller H; Kildalsen H; Kaur G; Gaestel M; Wetting HL; Mikkola I; Seternes OM
Sci Rep; 2020 Jul; 10(1):11388. PubMed ID: 32647362
[TBL] [Abstract][Full Text] [Related]
38. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.
Henriques A; Koliaraki V; Kollias G
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5546-E5555. PubMed ID: 29844172
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
